Objective:

To discuss the implications of postponing BCG vaccination on BCG-related complications in SCID patients following a policy change in Saudi Arabia.

Key Findings:

• Postponing BCG vaccination significantly reduced BCGitis in SCID patients from 46.1% to 2.6%.
• The study lacks a population-level impact assessment, focusing solely on SCID patients.
• No comparison was made with other international vaccination models.
• The study period coincided with the COVID-19 pandemic, which may have confounded results.
• Vaccine coverage rates and potential missed vaccinations were not reported.

Interpretation:

The commentary emphasizes the need for a comprehensive evaluation of vaccination policies that considers both the benefits for SCID patients and the risks for the broader population.

Limitations:

• The study's focus on a single-center population may not reflect the general population experience.
• Lack of multivariate analysis to account for confounding factors.
• No data on TB incidence or related complications among unvaccinated cohorts.

Conclusion:

A balanced policy evaluation must weigh the benefits for SCID infants against the risks posed to the larger population of immunocompetent neonates.